Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Farhang Ebrahimi"'
Autor:
Arun Umesh Mahtani, Muhammad Khalid Tahir, Inderbir Padda, Muhammad Haider, Farhang Ebrahimi, Philip Otterbeck, Jay Nfonoyim
Publikováno v:
JACC: Case Reports. 13:101780
Autor:
Rana Al-Zakhari, George Freg, Joseph Moussa, Farhang Ebrahimi, Harith Alataby, Elaheh Mossayebi
Publikováno v:
Journal of Medical Cases
Nephrogenic ascites is described as a clinical condition of refractory ascites in patients with end-stage renal disease (ESRD) on renal replacement therapy. This entity was first described in 1970. Many nephrologists do not believe in nephrogenic asc
Autor:
Arun Umesh Mahtani, Muhammad Khalid Tahir, Muhammad Haider, Inderbir Padda, Farhang Ebrahimi, Philip Otterbeck, Jay Nfonoyim
Publikováno v:
Journal of the American College of Cardiology. 81:3379
Publikováno v:
Endocrine Practice. 28:S74
Autor:
Krisha Arora, Urvi Bhavsar, Jay Nfonoyim, Farhang Ebrahimi, Jessie Saverimuttu, Muhammed Atere
Publikováno v:
The American Journal of Case Reports
Patient: Male, 36-year-old Final Diagnosis: Explosive pleuritis Symptoms: Abdominal pain Medication:— Clinical Procedure: — Specialty: Critical Care Medicine • Infectious Diseases • General and Internal Medicine • Nephrology • Pulmonology
Publikováno v:
Journal of Diabetes, Metabolic Disorders & Control. 5
Autor:
Mathew Clarke, Jamila Benmoussa, Amulya Penmetsa, Philip Otterbeck, Farhang Ebrahimi, Jay Nfonoyim
Publikováno v:
Journal of Endocrinology and Metabolism. 6:30-32
Autor:
Benjamin Chaucer, Fidencio Davalos, Wahib Zafar, Jamila Benmoussa, Farhang Ebrahimi, Jay Nfonoyim
Publikováno v:
Journal of Endocrinology and Metabolism. 6:95-96
Autor:
Vivette D. D'Agati, Glen S. Markowitz, Brooke Moore, Darren Kaufman, Farhang Ebrahimi, Kirk W. Foster, William H. Hines, Daniel Wolde, Michael B. Stokes
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 20(7)
BACKGROUND Treatment of rheumatoid arthritis with anti-tumour necrosis factor alpha (TNFalpha) agents may lead to autoantibody formation and flares of vasculitis, but renal complications are rare. METHODS We report the clinical and pathologic finding